Vitamin D Deficiency Increases Severity of Paclitaxel-Induced Peripheral Neuropathy

PURPOSE: Approximately 25% of patients receiving weekly paclitaxel for breast cancer require treatment disruptions to avoid severe, irreversible peripheral neuropathy (PN). Vitamin insufficiencies are PN risk factors in many diseases, but their relevance to chemotherapy-induced PN is unknown. METHOD...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Breast Cancer Res Treat
Prif Awduron: Jennaro, Theodore, Fang, Fang, Kidwell, Kelley M, Lavoie Smith, Ellen M., Vangipuram, Kiran, Burness, Monika L, Griggs, Jennifer J., Van Poznak, Catherine, Hayes, Daniel F., Henry, N. Lynn, Hertz, Daniel L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7945004/
https://ncbi.nlm.nih.gov/pubmed/32166478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05584-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg